MRI risk assessment for liver cancer in chronic liver disease
Part of Cancer, Digestive system clinical trials.
This study uses special MRI scans to better predict liver cancer risk in people with chronic liver disease. It may help doctors identify high-risk patients earlier and improve monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic liver disease with mild to moderate liver damage (Child-Pugh A or B).
- You meet the high-risk criteria for liver cancer as defined by current medical guidelines.
- You have had a special MRI scan with a contrast agent called Gd-EOB-DTPA.
- You have follow-up health data available for at least 5 years.
- You are not claustrophobic, have no severe kidney problems, and have not had liver surgery before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This study looks at MRI images taken as part of routine care to see if they can help predict future health problems in people with liver disease. If you already have an MRI scheduled for clinical reasons, this may help doctors better estimate risk over time.
This study tests a quicker MRI screening approach for people with cirrhosis to look for liver cancer early. It may help make liver cancer checkups faster and easier while still finding cancers when they are small.
This study compares MRI and ultrasound to see which is better at finding liver cancer early in people with liver cirrhosis. It also looks at body composition and other factors that could lead to worsening liver function.
This study uses a special MRI machine to take detailed images of the liver. It includes people newly diagnosed with liver cancer who haven't had treatment yet, as well as healthy volunteers for comparison. The goal is to see how well the machine works for different patients.
This trial uses a special type of MRI scan to see if doctors can predict how well a liver cancer treatment (called TACE) will work for you. The scan may help doctors understand your treatment response better.
Hear when a new Cirrhosis； Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.